Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Raw Materials (2016 - 2025)

CV Sciences' Raw Materials history spans 12 years, with the latest figure at $2.4 million for Q3 2025.

  • On a quarterly basis, Raw Materials fell 9.06% to $2.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a 9.06% decrease, with the full-year FY2024 number at $2.6 million, down 10.75% from a year prior.
  • Raw Materials hit $2.4 million in Q3 2025 for CV Sciences, down from $2.5 million in the prior quarter.
  • Over the last five years, Raw Materials for CVSI hit a ceiling of $4.6 million in Q3 2021 and a floor of $2.4 million in Q1 2025.
  • Historically, Raw Materials has averaged $3.3 million across 5 years, with a median of $3.2 million in 2023.
  • Biggest five-year swings in Raw Materials: fell 5.09% in 2021 and later fell 21.03% in 2022.
  • Tracing CVSI's Raw Materials over 5 years: stood at $4.0 million in 2021, then fell by 11.43% to $3.6 million in 2022, then decreased by 18.83% to $2.9 million in 2023, then dropped by 10.75% to $2.6 million in 2024, then fell by 5.5% to $2.4 million in 2025.
  • Business Quant data shows Raw Materials for CVSI at $2.4 million in Q3 2025, $2.5 million in Q2 2025, and $2.4 million in Q1 2025.